 |
PDBsum entry 3gbb
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Membrane protein
|
PDB id
|
|
|
|
3gbb
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Membrane protein
|
 |
|
Title:
|
 |
X-ray structure of iglur5 ligand-binding core (s1s2) in complex with msviii-19 at 2.10a resolution
|
|
Structure:
|
 |
Glutamate receptor, ionotropic kainate 1. Chain: a, b. Fragment: iglur5 ligand-binding core (s1s2). Synonym: glutamate receptor 5, glur-5, glur5. Engineered: yes
|
|
Source:
|
 |
Rattus norvegicus. Rat. Organism_taxid: 10116. Gene: glur5, grik1. Expressed in: escherichia coli. Expression_system_taxid: 562.
|
|
Resolution:
|
 |
|
2.10Å
|
R-factor:
|
0.201
|
R-free:
|
0.251
|
|
|
Authors:
|
 |
K.Frydenvang,P.Naur,M.Gajhede,J.S.Kastrup
|
Key ref:
|
 |
K.Frydenvang
et al.
(2009).
Full domain closure of the ligand-binding core of the ionotropic glutamate receptor iGluR5 induced by the high-affinity agonist dysiherbaine and the functional antagonist MSVIII-19.
J Biol Chem,
284,
14219-14229.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
19-Feb-09
|
Release date:
|
17-Mar-09
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P22756
(GRIK1_RAT) -
Glutamate receptor ionotropic, kainate 1 from Rattus norvegicus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
949 a.a.
255 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 1 residue position (black
cross)
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
284:14219-14229
(2009)
|
|
PubMed id:
|
|
|
|
|
| |
|
Full domain closure of the ligand-binding core of the ionotropic glutamate receptor iGluR5 induced by the high-affinity agonist dysiherbaine and the functional antagonist MSVIII-19.
|
|
K.Frydenvang,
L.L.Lash,
P.Naur,
P.A.Postila,
D.S.Pickering,
C.M.Smith,
M.Gajhede,
M.Sasaki,
R.Sakai,
O.T.Pentikäinen,
G.T.Swanson,
J.S.Kastrup.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The prevailing structural model for ligand activation of ionotropic glutamate
receptors posits that agonist efficacy arises from the stability and magnitude
of induced domain closure in the ligand-binding core structure. Here we describe
an exception to the correlation between ligand efficacy and domain closure. A
weakly efficacious partial agonist of very low potency for homomeric iGluR5
kainate receptors, 8,9-dideoxy-neodysiherbaine (MSVIII-19), induced a fully
closed iGluR5 ligand-binding core. The degree of relative domain closure, ~30
degrees , was similar to that we resolved with the structurally related
high-affinity agonist dysiherbaine (DH), and to that of L-glutamate. The
pharmacological activity of MSVIII-19 was confirmed in patch-clamp recordings
from transfected HEK293 cells, where MSVIII-19 predominantly inhibits iGluR5-2a,
with little activation apparent at a high concentration (1 mM) of MSVIII-19
(<1% of mean glutamate-evoked currents). To determine the efficacy of the
ligand quantitatively, we constructed concentration-response relationships for
MSVIII-19 following potentiation of steady-state currents with concanavalin A
(EC50 3.6 muM) and on the non-desensitizing receptor mutant
iGluR5-2b(Y506C/L768C) (EC50 8.1 muM). MSVIII-19 exhibited a maximum of 16% of
full agonist efficacy as measured in parallel recordings with glutamate.
Molecular dynamics simulations and electrophysiological recordings confirm that
the specificity of MSVIII-19 for iGluR5 is partly attributable to inter-domain
hydrogen bonds residues Glu441 and Ser721 in the iGluR5-S1S2 structure. The
weaker interactions of MSVIII-19 with iGluR5 compared to DH, together with
altered stability of the inter-domain interaction, may be responsible for the
apparent uncoupling of domain closure and channel opening in this kainate
receptor subunit.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Chemical structures of dysiherbaine and MSVIII-19. The two
compounds differ in positions C8 (NH-Me substituent in DH versus
H in MSVIII-19) and C9 (OH versus H).
|
 |
Figure 3.
MSVIII-19 induces full domain closure in the ligand-binding
core of iGluR5. A, superimposition of the MSVIII-19 (cyan), DH
(yellow), and l-glutamate (Protein Data Bank code 1YCJ, molecule
A; salmon) complexes with iGluR5-S1S2 on D1 residues. B,
superimposition of the MSVIII-19 (cyan) and UBP302 (Protein Data
Bank code 2F35, molecule A; blue) complexes with iGluR5-S1S2 on
D1 residues. The high degree of domain closure introduced by
MSVIII-19 compared with UBP302 is evident from the change of the
D2 domain position.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2009,
284,
14219-14229)
copyright 2009.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.Y.Lau,
and
B.Roux
(2011).
The hidden energetics of ligand binding and activation in a glutamate receptor.
|
| |
Nat Struct Mol Biol,
18,
283-287.
|
 |
|
|
|
|
 |
C.S.Qiu,
L.Lash-Van Wyhe,
M.Sasaki,
R.Sakai,
G.T.Swanson,
and
R.W.Gereau
(2011).
Antinociceptive effects of MSVIII-19, a functional antagonist of the GluK1 kainate receptor.
|
| |
Pain,
152,
1052-1060.
|
 |
|
|
|
|
 |
G.M.Alushin,
D.Jane,
and
M.L.Mayer
(2011).
Binding site and ligand flexibility revealed by high resolution crystal structures of GluK1 competitive antagonists.
|
| |
Neuropharmacology,
60,
126-134.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.L.Mayer
(2011).
Structure and mechanism of glutamate receptor ion channel assembly, activation and modulation.
|
| |
Curr Opin Neurobiol,
21,
283-290.
|
 |
|
|
|
|
 |
R.E.Hubbard
(2011).
Structure-based drug discovery and protein targets in the CNS.
|
| |
Neuropharmacology,
60,
7.
|
 |
|
|
|
|
 |
A.Birdsey-Benson,
A.Gill,
L.P.Henderson,
and
D.R.Madden
(2010).
Enhanced efficacy without further cleft closure: reevaluating twist as a source of agonist efficacy in AMPA receptors.
|
| |
J Neurosci,
30,
1463-1470.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
C.Shelley,
and
S.G.Cull-Candy
(2010).
Desensitization and models of receptor-channel activation.
|
| |
J Physiol,
588,
1395-1397.
|
 |
|
|
|
|
 |
L.L.Lash-Van Wyhe,
P.A.Postila,
K.Tsubone,
M.Sasaki,
O.T.Pentikäinen,
R.Sakai,
and
G.T.Swanson
(2010).
Pharmacological activity of C10-substituted analogs of the high-affinity kainate receptor agonist dysiherbaine.
|
| |
Neuropharmacology,
58,
640-649.
|
 |
|
|
|
|
 |
P.A.Postila,
G.T.Swanson,
and
O.T.Pentikäinen
(2010).
Exploring kainate receptor pharmacology using molecular dynamics simulations.
|
| |
Neuropharmacology,
58,
515-527.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |